APA (7th ed.) Citation

Yu, T., Wang, X., Zhi, T., Zhang, J., Wang, Y., Nie, E., . . . Liu, N. (2018). Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype. Cancer letters, 433, 210-220. https://doi.org/10.1016/j.canlet.2018.06.041

Chicago Style (17th ed.) Citation

Yu, Tianfu, XieFeng Wang, Tongle Zhi, Junxia Zhang, Yingyi Wang, Er Nie, Fengqi Zhou, Yongping You, and Ning Liu. "Delivery of MGMT MRNA to Glioma Cells by Reactive Astrocyte-derived Exosomes Confers a Temozolomide Resistance Phenotype." Cancer Letters 433 (2018): 210-220. https://doi.org/10.1016/j.canlet.2018.06.041.

MLA (9th ed.) Citation

Yu, Tianfu, et al. "Delivery of MGMT MRNA to Glioma Cells by Reactive Astrocyte-derived Exosomes Confers a Temozolomide Resistance Phenotype." Cancer Letters, vol. 433, 2018, pp. 210-220, https://doi.org/10.1016/j.canlet.2018.06.041.